Mark E. Jones

1.5k total citations
14 papers, 1.2k citations indexed

About

Mark E. Jones is a scholar working on Molecular Medicine, Infectious Diseases and Clinical Biochemistry. According to data from OpenAlex, Mark E. Jones has authored 14 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Molecular Medicine, 5 papers in Infectious Diseases and 5 papers in Clinical Biochemistry. Recurrent topics in Mark E. Jones's work include Antibiotic Resistance in Bacteria (12 papers), Bacterial Identification and Susceptibility Testing (5 papers) and Antimicrobial Resistance in Staphylococcus (5 papers). Mark E. Jones is often cited by papers focused on Antibiotic Resistance in Bacteria (12 papers), Bacterial Identification and Susceptibility Testing (5 papers) and Antimicrobial Resistance in Staphylococcus (5 papers). Mark E. Jones collaborates with scholars based in United States, Netherlands and Germany. Mark E. Jones's co-authors include Clyde Thornsberry, Daniel F. Sahm, James A. Karlowsky, Deborah C. Draghi, Ian R. Friedland, J. Verhoef, Ad C. Fluit, F.-J. Schmitz, Gregory Volturo and Ian A. Critchley and has published in prestigious journals such as Journal of Clinical Microbiology, Antimicrobial Agents and Chemotherapy and Journal of Antimicrobial Chemotherapy.

In The Last Decade

Mark E. Jones

14 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mark E. Jones United States 13 743 402 268 266 226 14 1.2k
D. Sofianou Greece 16 616 0.8× 278 0.7× 270 1.0× 151 0.6× 183 0.8× 39 1.1k
Noriel Mariano United States 19 780 1.0× 401 1.0× 209 0.8× 220 0.8× 121 0.5× 31 1.1k
Lisa Saidel‐Odes Israel 13 751 1.0× 396 1.0× 225 0.8× 286 1.1× 208 0.9× 40 1.1k
Gill Smollan Israel 15 662 0.9× 277 0.7× 264 1.0× 281 1.1× 239 1.1× 23 1.0k
A.T. Bernards Netherlands 22 699 0.9× 328 0.8× 373 1.4× 178 0.7× 150 0.7× 37 1.4k
Sunita Mohapatra United States 6 706 1.0× 344 0.9× 202 0.8× 236 0.9× 160 0.7× 10 1.0k
Sofia Maraki Greece 20 638 0.9× 611 1.5× 181 0.7× 213 0.8× 167 0.7× 38 1.3k
Kim Nichol Canada 19 756 1.0× 674 1.7× 298 1.1× 179 0.7× 207 0.9× 33 1.5k
Cristina Pitart Spain 19 633 0.9× 378 0.9× 267 1.0× 188 0.7× 188 0.8× 63 1.2k
Vered Schechner Israel 15 638 0.9× 534 1.3× 233 0.9× 298 1.1× 218 1.0× 47 1.3k

Countries citing papers authored by Mark E. Jones

Since Specialization
Citations

This map shows the geographic impact of Mark E. Jones's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark E. Jones with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark E. Jones more than expected).

Fields of papers citing papers by Mark E. Jones

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark E. Jones. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark E. Jones. The network helps show where Mark E. Jones may publish in the future.

Co-authorship network of co-authors of Mark E. Jones

This figure shows the co-authorship network connecting the top 25 collaborators of Mark E. Jones. A scholar is included among the top collaborators of Mark E. Jones based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mark E. Jones. Mark E. Jones is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

14 of 14 papers shown
1.
Jones, Mark E., James A. Karlowsky, Deborah C. Draghi, et al.. (2004). Antibiotic susceptibility of bacteria most commonly isolated from bone related infections: the role of cephalosporins in antimicrobial therapy. International Journal of Antimicrobial Agents. 23(3). 240–246. 18 indexed citations
2.
Karlowsky, James A., Mark E. Jones, Deborah C. Draghi, et al.. (2004). Prevalence and antimicrobial susceptibilities of bacteria isolated from blood cultures of hospitalized patients in the United States in 2002. Annals of Clinical Microbiology and Antimicrobials. 3(1). 7–7. 168 indexed citations
3.
Master, Ronald N., Deborah C. Draghi, Mark E. Jones, et al.. (2004). Tracking the implementation of NCCLS M100-S12 expanded-spectrum cephalosporin MIC breakpoints for nonmeningeal isolates of Streptococcus pneumoniae by clinical laboratories in the United States during 2002 and 2003. Annals of Clinical Microbiology and Antimicrobials. 3(1). 1–1. 35 indexed citations
4.
Flamm, Robert K., et al.. (2004). Factors Associated with Relative Rates of Antibiotic Resistance in Pseudomonas aeruginosa Isolates Tested in Clinical Laboratories in the United States from 1999 to 2002. Antimicrobial Agents and Chemotherapy. 48(7). 2431–2436. 98 indexed citations
5.
Blosser-Middleton, Renée S., D.F. Sahm, Clyde Thornsberry, et al.. (2003). Antimicrobial susceptibility of 840 clinical isolates of Haemophilus influenzae collected in four European countries in 2000-2001. Clinical Microbiology and Infection. 9(5). 431–436. 17 indexed citations
6.
7.
8.
Karlowsky, James A., Mark E. Jones, Clyde Thornsberry, Ian R. Friedland, & Daniel F. Sahm. (2003). Trends in Antimicrobial Susceptibilities among Enterobacteriaceae Isolated from Hospitalized Patients in the United States from 1998 to 2001. Antimicrobial Agents and Chemotherapy. 47(5). 1672–1680. 109 indexed citations
9.
Karlowsky, James A., Deborah C. Draghi, Mark E. Jones, et al.. (2003). Surveillance for Antimicrobial Susceptibility among Clinical Isolates of Pseudomonas aeruginosa and Acinetobacter baumannii from Hospitalized Patients in the United States, 1998 to 2001. Antimicrobial Agents and Chemotherapy. 47(5). 1681–1688. 284 indexed citations
10.
Karlowsky, James A., Laurie J. Kelly, Clyde Thornsberry, et al.. (2002). Susceptibility to fluoroquinolones among commonly isolated Gram-negative bacilli in 2000: TRUST and TSN data for the United States. International Journal of Antimicrobial Agents. 19(1). 21–31. 79 indexed citations
11.
Karlowsky, James A., Mark E. Jones, Clyde Thornsberry, et al.. (2001). Prevalence of antimicrobial resistance among urinary tract pathogens isolated from female outpatients across the US in 1999. International Journal of Antimicrobial Agents. 18(2). 121–127. 72 indexed citations
12.
Jones, Mark E.. (1999). Towards better surveillance of bacterial antibiotic resistance. Clinical Microbiology and Infection. 5(2). 61–63. 5 indexed citations
13.
Schmitz, Franz‐Josef, et al.. (1999). Class I integrons: prevalence and impact on antibiotic susceptibility in 278 consecutive unrelated Gram-negative blood isolates. Clinical Microbiology and Infection. 5(8). 496–498. 12 indexed citations
14.
Fluit, Ad C., et al.. (1998). Class I integrons in Gram-negative isolates from different European hospitals and association with decreased susceptibility to multiple antibiotic compounds. Journal of Antimicrobial Chemotherapy. 42(6). 689–696. 210 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by D. Sofianou Breakdown of academic impact, for papers by Noriel Mariano Breakdown of academic impact, for papers by Lisa Saidel‐Odes Breakdown of academic impact, for papers by Gill Smollan Breakdown of academic impact, for papers by A.T. Bernards Breakdown of academic impact, for papers by Sunita Mohapatra Breakdown of academic impact, for papers by Sofia Maraki Breakdown of academic impact, for papers by Kim Nichol Breakdown of academic impact, for papers by Cristina Pitart Breakdown of academic impact, for papers by Vered Schechner
Rankless by CCL
2026